Compared with naproxen, etodolac appears to reduce the risk of clinically significant upper GI events

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1465, 2004-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increasing use of aspirin, NSAIDs and anticoagulants appears to be associated with an increased risk of significant GI haemorrhage

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Prevalence and risk factors for clinically significant upper gastrointestinal bleeding in patients with severe acute pancreatitis

Journal of Digestive Diseases, Vol. 16, Iss. 1, 2015-01 ,pp. : 37-42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Esomeprazole may reduce NSAID-induced upper GI disorders

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Esomeprazole may reduce NSAID-induced upper GI disorders

Reactions Weekly, Vol. 1, Iss. 1053, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Etoricoxib: upper GI events less common than with diclofenac

Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite